Management

Management

jj management
Juan José Chacón-Quirós
CEO & Founder
Mr. Chacón-Quirós is the Founder, Chief Executive Officer, and Board Director of Establishment Labs® (NASDAQ : ESTA). Mr. Chacón Quirós has been involved in several sectors of the aesthetics industry, serving for a decade as General Manager of an aesthetic medical device distribution business in Latin America and prior to this as Business Development Manager of a renowned plastic and reconstructive surgery clinic. He has authored and co-authored more than 50 patents that are helping advance technology in areas like implants and surfaces, RFID and biosensors, 3D technology, and surgical instruments development. Served as President of the Rugby Federation of Costa Rica and is currently on the board of South America Rugby and the board of directors of the Latin American and Caribbean Business Forum. Mr. Chacón-Quirós received a degree from the Academie de Poitiers (Economie) and attended the University of Massachusetts at Amherst. He holds the MIT Sloan Advanced Certificate for Executives (ACE) in Management, Innovation, and Technology.
Jeffrey Bettinger
Jeffrey Bettinger
Global Head of People
Jeffrey Bettinger joined Establishment Labs® in November 2021 from Nu Skin, a global leader in beauty and wellness, where he served as the Chief People and Places Officer. In addition, he held a variety of executive and senior leadership roles in medical devices, financial services, pharmaceuticals, and engineering. Some of his past employers are USAA, Petco, State Farm, Fluor, and Walmart. He has had the honor of receiving regional and national recognition for leadership development and culture transformation. Moreover, he has been published on a variety of human capital topics. Mr. Bettinger has an extensive academic background, starting with a bachelor’s degree in communication, a master’s degree in organizational communication and educational administration from Idaho State University, and a Master’s in Business Administration from Liberty University. 
Heather Brennan
Heather Brennan
General Manager, Global Markets

Dr. Heather Brennan, an experienced medical device executive that joined our lines in 2021 and currently serves as the Head of US Commercial Operations for Establishment Labs®. She has 20 years of experience in medical device and regenerative medicine both in a research and business capacity. Before joining Establishment Labs®, Heather was the Vice President and General Manager of MTF Biologics’ Plastic and Reconstructive Surgery Franchise, where she developed and led the strategic direction of the business growing revenue by 500% and solidifying a leadership spot for the company in post-mastectomy breast reconstruction. Before joining MTF Biologics, she was the Director of Program Management at Integra LifeSciences where she managed the introduction of an extremity reconstruction and regenerative product portfolio into the domestic market. She has a passion for women’s health and has spent the last 15 years of her career dedicated to optimizing care for women undergoing restoration after breast cancer. A scholar from Lehigh University with a Mechanical Engineering degree and a doctorate in Biomedical Engineering from Rutgers University.

Rosalyn
Rosalyn Cole d’Incelli
Head of Clinical and Medical Affairs
Rosalyn d’Incelli has been a part of Establishment Labs® since May of 2020 as the company’s Head of Clinical and Medical Affairs, bringing to the company over 20 years of medical device experience.  In this role, she drives global clinical and medical strategy and execution and leads U.S. Regulatory Affairs. Prior to joining us, she was with Sientra Inc., for 11 years as the Vice President of Clinical and Medical Affairs. She was responsible for U.S. PMA approval, Medical Education, PR, Publications, and the company’s scientific content.  She represented the company with FDA, media, and medical education events and congresses. Preceding to Sientra, Ms. d’Incelli held similar roles with PMA approvals at Mentor/Johnson & Johnson and Inamed (now Allergan/AbbVie). She holds a B.A. in communication/market research from the University of California, Santa Barbara, and is board certified in SoCRA and RAP.
Salvador Dada
Salvador Dada
Chief Operating Officer
Mr. Dada was one of the founding members of the company back in 2004. Salvador initially led the implementation of Establishment Labs´ operations in Costa Rica and the successful certification of the Motiva Implants® product family by the European Union and other high vigilance countries. In February 2016 he was appointed as our Chief Operating Officer where he led the expansion of the operations to Brazil, Belgium, and in recent years, to several other European countries where direct commercial operations were launched. Due to health issues, he resigned from his position as COO and now serves as Head of Special Projects. Mr. Dada served in various engineering roles at Allergan Medical from 2007 to 2009 and in a variety of production and manufacturing roles at Establishment Biotech, S.A. from 2004 to 2006. He has an undergraduate and licentiate degree in Industrial Engineering from the University of Costa Rica.
Roberto de Mezerville
Roberto de Mezerville
Chief Technology Officer
Since 2009, Roberto has risen through several positions in our company, in the areas of quality management, research and development, innovation, and regulatory and clinical affairs and has been our CTO heading of Research, Development, and Innovation since January 2018. Roberto has led several impactful research projects that have been key for the science-based design of our femtech technologies, and authored peer reviewed publications. From 2006 to 2009, served in various engineering and quality manager positions with Allergan Medical Costa Rica. He has a bachelor's degree in Business Administration from Universidad Interamericana de Costa Rica and a bachelor's degree in Industrial Environmental Health and Safety Engineering from Instituto Tecnologico de Costa Rica.
Raj Denhoy
Raj Denhoy
Chief Financial Officer
Raj has been part of Establishment Labs® since February 2021. Before his current role as Chief Financial Officer, he served as the company’s Head of Strategy and Investor Relations. Raj joined the company from Jefferies Group, LLC where he was a Managing Director and led the U.S. medical device research team for eleven years, including coverage of Establishment Labs®. He covered the medical device industry as an equity research analyst for over twenty years. Raj has an impressive academic portfolio, including a bachelor’s degree in biology from UC Berkeley, a master’s degree in physiology from Georgetown University, to an MBA from Cornell University.
Phillip Modesti
Phillip Modesti
Global Head of Medical Education

With over 20 years in the medical industry, he has worked for well-established organizations such as Merck, Covidien (now Medtronic), SkinCeuticals/L'Oreal, Siemens, and most recently Hologic’s Breast and Skeletal Health Division. Phillip brings extensive experience in building strategic teams while creating organizational insights for marketing, clinical affairs, and R&D through Key Opinion Leaders who help shape the future with their respective expertise. His background includes sales, sales management and training, leadership development, and medical education. Phillip has been instrumental in developing strategic partnerships with key customers, creating fellowship programs, developing limited market release programs, and building Medical Education teams focusing on peer-to-peer education through an extensive network of Key Opinion Leaders. His medical education experience includes areas in Minimally Invasive Surgery, Breast Radiology, Minimally Invasive Breast Surgery, Ultrasound, and Skeletal Health.

Phillip has a Master of Science degree from Barry University in Miami Shores, Florida, and a bachelor of science degree from Castleton University, Castleton, Vermont, where he was recently recognized as the 2021 Outstanding Alumni of the Year.

Ross Mansbach
Ross Mansbach
General Counsel & Chief Compliance Officer
Ross Mansbach joined the company in August 2022 as the General Counsel and Chief Compliance Officer.  He was previously at Avanos Medical, Inc., a publicly traded medical device company, where he held positions including Senior Vice President, Interim General Counsel and Corporate Secretary and Vice President, Deputy General Counsel and Corporate Secretary, between November 2014 and March 2022.  Prior to that, Mr. Mansbach held positions of increasing responsibility in the Legal Department at Kimberly-Clark Corporation for more than ten years.  Earlier in his career, Mr. Mansbach was a partner at the law firm of Powell Goldstein Frazer & Murphy, now known as Bryan Cave.  He was also a judicial clerk for a judge on the United States District Court for the Northern District of Illinois. Mr. Mansbach received his B.A from Yale College and his J.D. from The University of Chicago.